Pharma Focus Asia

Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Johnson & Johnson Discovered First-of-its-kind RYBREVANT® for the Treatment of Patients with Non-Small Cell Lung Cancer

Johnson & Johnson has introduced RYBREVANT® as a groundbreaking therapy for the initial treatment of individuals diagnosed with non-small cell lung cancer...

Iovance Biotherapeutics Developed First-of-its-Kind AMTAGVI™ for Advanced Melanoma

Iovance Biotherapeutics has developed first-of-its-kind AMTAGVI™ cell therapy for a solid tumour cancer and first treatment option for advanced melanoma....

Bayer Introduces Breakthrough Therapy BAY 2927088 for Non-Small Cell Lung Cancer

Bayer has introduced a groundbreaking therapy named BAY 2927088 for addressing adult patients afflicted with unresectable or metastatic non-small cell lung cancer...

Nuvalent Discovered Novel NVL-520 for the Treatment of Non-Small Cell Lung Cancer

Nuvalent has developed NVL-520, a new treatment for patients with ROS1-positive metastatic non-small cell lung cancer who have previously undergone treatment with two or more ROS1 tyrosine kinase inhibitors...

Biogen Developed SKYCLARYS® (omaveloxolone), the First Therapy to treat Friedreich’s Ataxia

Biogen has developed SKYCLARYS®, marking a significant breakthrough as the inaugural therapeutic option for addressing Friedreich’s ataxia in adults and adolescents aged 16 years and older....

Chugai Pharmaceutical Develops Novel Crovalimab Antibody for the Treatment of Paroxysmal Nocturnal Haemoglobinuria

Chugai Pharmaceutical has developed a groundbreaking treatment named crovalimab, a humanised monoclonal antibody targeting complement C5, designed particularly for adults and adolescents...

Takeda Discovered First-of-its-kind Oral Treatment for Eosinophilic Oesophagitis

Takeda has discovered first-of-its-kind EOHILIA , the only FDA-approved oral therapy tailored for individuals aged 11 and above grappling with eosinophilic oesophagitis...

Regeneron Pharmaceuticals Introduced Dupixent® First and Only Treatment for Children with Eosinophilic Oesophagitis (EoE)

Regeneron Pharmaceuticals has introduced Dupixent® for treating paediatric patients aged 1 to 11 years with eosinophilic oesophagitis, weighing at least 15 kg. Dupixent, a fully human monoclonal antibody...

Alector Launched Breakthrough Latozinemab Antibody for Progranulin Gene Mutation (FTD-GRN)

Alector has introduced atozinemab, a groundbreaking investigational human monoclonal antibody crafted to obstruct sortilin, thereby boosting progranulin levels, offering promise in treating frontotemporal dementia with a progranulin gene mutation...

RadioMedix and Orano Moed Discovered Novel AlphaMedixTM for Gastroenteropancreatic Neuroendocrine Tumours

RadioMedix and Orano Moed have jointly developed a groundbreaking treatment named AlphaMedix™ for adults with unresectable or metastatic gastroenteropancreatic neuroendocrine tumours...

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024
Want better clinical trial outcomes?